Clinical Trial Update: Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating reduced intensity haploidentical transplantation for primary or secondary myelofibrosis is currently recruiting at Fred Hutchi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Primary Myelofibrosis, Secondary Myelofibrosis | Phase 2 | Status: RECRUITING